97 new products for the prevention or treatment of HIV/AIDS and related conditions are currently in human clinical trials, or awaiting approval by the FDA, according to the Pharmaceutical Research and Manufacturers of America. These products in development include 23 vaccines and 54 antivirals.
While not all these products will be approved, it’s more encouraging news in the fight against HIV/AIDS following from yesterday’s announcement by UNAIDS of a global decline in HIV infection rates (UNAIDS report: 33.4 million worldwide have HIV, but infections slow). UNAIDS estimates that new HIV infections worldwide have been reduced by 17% over the past eight years.
Since the introduction of anti-retroviral therapy in 1995, the US Centers for Disease Control and Prevention (CDC) estimates that the annual number of deaths in the US due to AIDS has dropped by more than 70%.